Qube Research & Technologies Ltd

CIK 0001729829 · LONDON, null · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Qube Research & Technologies Ltd reported 3,406 positions worth $107.65B as of June 30, 2026 (13F filed August 14, 2026). Largest holding: AMZN (1.0%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$107.65B
2026 Q2
Positions
3,406
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
8.2%
Est. Net Flow (Q)
2026 Q2
10 / 3406 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1AMZNAMAZON COM INCSH$1.11B1.03%4,661,958
2AAPLAPPLE INCSH$1.05B0.98%3,645,083
3SPYSTATE STR SPDR S&P 500 ETF TSH$987.7M0.92%1,322,649
4CVXCHEVRON CORPORATIONSH$941.5M0.87%5,679,785
5SNDKSANDISK CORPSH$931.4M0.87%409,650
6MUMICRON TECHNOLOGY INCSH$871.0M0.81%754,752
7JPMJPMORGAN CHASE & COSH$840.1M0.78%2,566,594
8GSGOLDMAN SACHS GROUP INCSH$728.9M0.68%720,663
9MUMICRON TECHNOLOGY INCPUT$683.3M0.63%592,000
10NVDANVIDIA CORPORATIONSH$677.9M0.63%3,388,022

The free plan shows the top 10 positions. The remaining 3396 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Qube Research & Technologies Ltd hold as of Q2 2026?

Qube Research & Technologies Ltd reported 3406 positions worth $107.65B in its Q2 2026 13F filing. Largest positions: AMZN (1.0%), AAPL (1.0%), SPY (0.9%), CVX (0.9%) and SNDK (0.9%).

What did Qube Research & Technologies Ltd buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Qube Research & Technologies Ltd sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.